bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.06.23.733831

Healthy-to-Stroke Translation of EEG-Based BMIs: EEG Characterization and Reinforcement Learning-Based Decoder Evaluation

Abstract

PurposeEEG-based brain-machine interfaces (BMIs) may support assistive technologies for individuals with stroke-related motor impairment by translating neural activity into control commands for external devices. However, post-stroke neural reorganization and interindividual EEG variability challenge reliable decoding. This study characterized motor imagery EEG features in healthy and acute stroke participants and evaluated whether population-trained Q-learning Kernel Temporal Difference (Q-KTD) decoders could improve individual stroke decoding through transfer learning. These analyses assess the feasibility of healthy-to-stroke translation for EEG-based BMI neural decoding. Materials and MethodsPublicly available motor imagery EEG datasets from healthy participants (n = 109) and individuals with acute stroke (n = 50) were analyzed using left- and right-hand motor imagery trials. The datasets were selected because of their relatively large sample sizes and comparable motor imagery tasks. EEG characterization included baseline and motor imagery-period band power, ERD/ERS, hemispheric asymmetry, and time-frequency representations. For Q-learning Kernel Temporal Difference (Q-KTD) decoding, filtered time-domain EEG from 0- 0.5 s after motor imagery onset was used as the neural-state input. A Q-KTD model trained on the healthy population was transferred to individual stroke participants, and repeated Monte Carlo simulations compared decoding performance with and without transfer learning across multiple learning epochs. ResultsHealthy and acute stroke participants showed shared motor imagery-related EEG structure, including post-onset mu-band suppression, while the stroke group exhibited greater interparticipant variability, more diffuse time- frequency modulation, and altered hemispheric asymmetry. No channel-level healthy-stroke differences in windowed band power remained significant after false discovery rate correction. Healthy-source transfer learning improved first-epoch Q-KTD success rates in 29 of 50 stroke participants (58%). Across all participants, mean success rate increased from 49.46% without transfer learning to 51.82% with transfer learning. Among participants showing positive transfer, the mean gain was 7.34% and the maximum gain was 18.75%. However, 21 participants showed negative transfer, demonstrating substantial subject-level variability. ConclusionHealthy-source Q-KTD transfer learning improved first-epoch motor imagery BMI decoding for a majority of acute stroke participants, supporting the offline feasibility of population-informed Q-KTD decoding in stroke. These early performance gains may reduce subject-specific calibration burden, although substantial interparticipant variability and negative transfer indicate the need for individualized transfer-selection or adaptation strategies. Assistive Technology ImplicationsO_LIEEG-based brain-machine interfaces may support assistive technologies for individuals with stroke-related motor impairment by translating motor imagery-related neural activity into control commands for external devices. C_LIO_LIHealthy-to-stroke transfer learning may improve early BMI neural-decoder performance and potentially reduce the amount of subject-specific calibration required. C_LIO_LIThe findings support the offline feasibility of Q-KTD for motor imagery BMI neural decoding in individuals with acute stroke. C_LIO_LISubstantial interparticipant variability and negative transfer suggest that individualized source-model selection or adaptation strategies may be needed for reliable post-stroke BMI implementation. C_LIO_LIPhysiological EEG characteristics, including ERD/ERS and hemispheric asymmetry, may provide candidate markers for future transfer-selection strategies, although their predictive value requires direct validation. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Via, Z., Kruse, A., Thapa, B. R., Bae, J.. 2026-06-29. Healthy-to-Stroke Translation of EEG-Based BMIs: EEG Characterization and Reinforcement Learning-Based Decoder Evaluation. https://doi.org/10.64898/2026.06.23.733831

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Wall stiffening is a primary contributor to motility loss in Crohn's disease: an electromechanical modeling study

Fibrotic strictures are among the most disabling complications of Crohn's disease, permanently narrowing the bowel and impairing motility, yet no approved therapy reverses them. Chronic inflammation alters pacemaker-network coupling, smooth-muscle excitability, and calcium-dependent contractility, while fibrosis thickens the bowel wall, narrows the lumen, and changes tissue mechanics. The relative contributions of these coupled electrical, contractile, and structural alterations to motility loss remain unclear. To address this gap, we develop an integrated electromechanical finite-element framework for fibrostenosing Crohn's disease that couples a fibrosis-driven growth model with a FitzHugh-Nagumo electromechanical model. A full-factorial 25 design of experiments is used to quantify the relative effects of electrical diffusivity, excitation threshold, peak active stress, wall stiffness, and hypertrophic remodeling on cyclic lumen-volume deformation. Motility is quantified by the standard deviation of lumen volume over one contraction cycle. Within the parameter ranges examined, increased wall stiffness emerged as the dominant contributor to motility loss, followed by impaired smooth-muscle contractility. Changes in excitation threshold, hypertrophic remodeling, and electrical diffusivity produced substantially smaller effects. Pairwise interactions were small relative to the dominant main effects, indicating that the mechanisms contributed largely through their individual effects. Our findings suggest that limiting wall stiffening while preserving smooth-muscle contractile function may provide a therapeutic strategy for maintaining intestinal motility in fibrostenosing Crohn's disease.

bioengineering↗

Lactate Receptor Activation Alleviates Senescence and Preserves Homeostasis of Aged Arteries

Arteries are among the first tissues to exhibit age-related dysfunction, yet the metabolic mechanisms driving vascular senescence remain poorly understood. Here, analysis of human aortic transcriptomic data identified HCAR1, encoding the lactate receptor GPR81, as one of the genes most significantly downregulated with age. We therefore investigated whether age-associated loss of GPR81 contributes to cellular senescence within the vessel wall. Senescent human endothelial cells and vascular smooth muscle cells accumulated neutral and oxidized lipids and exhibited increased labile iron and ferroptosis. Silencing GPR81 in early-passage cells recapitulated this metabolic phenotype together with multiple hallmarks of cellular senescence. Moreover, endothelial-specific deletion of GPR81 in young mice was sufficient to induce senescent cell accumulation, impaired lipid homeostasis, endothelial dysfunction, and elastin disorganization. Conversely, pharmacological activation of GPR81 with the agonist CHBA restored fatty acid metabolism, promoted glycolytic reprogramming, and attenuated ferroptotic stress and senescence-associated phenotypes. In lamin A knock-in (LAKI) progeroid mice, CHBA reduced arterial lipid accumulation and cellular senescence, shifted vascular cell composition toward a youthful state, improved endothelial integrity, and restored extracellular matrix homeostasis. Together, these findings identify age-associated loss of GPR81 as a driver of vascular metabolic dysfunction and cellular senescence and establish pharmacological GPR81 activation as a promising therapeutic strategy for preserving vascular homeostasis and mitigating age-associated cardiovascular disease.

bioengineering↗

Targeted and bilateral blood flow monitoring in middle cerebral artery using diffuse correlation spectroscopy

Objective: To develop and validate a dual-probe Diffuse Correlation Spectroscopy (DCS) system for non-invasive and simultaneous, monitoring of cerebral blood flow (CBF) in the bilateral Middle Cerebral Artery (MCA) territories, and expanding the utility of conventional DCS limited to cortical-volume-based CBF measurements to vessel-specific cerebral perfusion monitoring. Methods: A dual-probe DCS system was designed for non-invasive monitoring of MCA-specific perfusion. Probe placement and protocol optimization study has been performed using anatomical landmarks, motor and speech activation tasks in healthy volunteers. System stability and repeatability were further evaluated in a pilot cohort of 30 healthy (age, 25{+/-}7 years) participants using optimized probe position and protocol. A bilateral MCA ischemic Lacunar Infract stroke case report also validated the feasibility of the system in clinical settings. Results: Measurements demonstrated superior sensitivity towards MCA-territory perfusion at targeted probe locations compared to off-MCA positions. In pilot cohort, significant increase of 30.34 {+/-} 21.56% and 36.48 {+/-} 21.22% in rCBF corresponding to hand squeeze and speech task respectively showed reproducible physiological responsiveness of the system (p<0.001). Measurement done on a patient with bilateral MCA ischemic Lacunar Infract stroke showed a significant change of 30% during speech for both the MCAs but no significant change is observed for hand squeeze tasks. Conclusion: The custom built dual-probe DCS system enables non-invasive, operator-independent, targeted and continuous monitoring of rCBF within bilateral MCA territories. Significance: This approach enables the potential use of DCS system for bilateral and vessel-specific monitoring of cerebral perfusion in the MCA territories.

bioengineering↗